1583: The Biotech Transforming Disease Detection and Monitoring Drug Response

1583: The Biotech Transforming Disease Detection and Monitoring Drug Response

As regular listeners will know, I am fascinated by our new proactive rather than reactive approach to healthcare, and the role tech plays in that change. We already monitor our steps, heart rate, calorie intake and can even have an ECG machine on hand. Today, Caroline Loew, CEO of Glympse, joins me in a conversation about biotech innovation.

Caroline shares their mission to detect diseases earlier and help develop better therapies so that people don't become patients and return to health faster. We discuss their novel technology: activity-based biosensors that are bioengineered and tunable to any protease-mediated disease.

I also learn how Glympse's technology can measure and predict the trajectory of a disease in a non-invasive, real-time, functional readout that is clinically actionable.

Glympse Bio is pioneering an in vivo sensing technology dedicated to transforming disease monitoring. The company has built a product engine enabling the rapid development of tunable and bioengineered activity sensors for multiple indications, including fibrosis, cancer, immunology, and infectious diseases.

The technology has been validated in 10 different diseases using multiple delivery methods and a broad range of analytical readouts. Glympse aims to improve healthcare globally by serving the needs of patients, clinicians, researchers, drug developers, and payors to help advance the science and our understanding of human diseases.

Avsnitt(2000)

Qlik Connect: James Fisher On Turning AI Into a Business Strategy

Qlik Connect: James Fisher On Turning AI Into a Business Strategy

What does it really take to move beyond AI experimentation and build something a business can rely on? Recording live from Qlik Connect, I sat down with James Fisher, Chief Strategy Officer at Qlik, t...

16 Apr 23min

3483: How Glean Is Securing The Next Wave Of AI Agents In The Enterprise

3483: How Glean Is Securing The Next Wave Of AI Agents In The Enterprise

What happens when your AI agents start making decisions faster than your security team can even see them? In this episode, I sit down with Sunil Agrawal, Chief Information Security Officer at Glean, t...

15 Apr 32min

Qlik Connect: Mike Capone On Agentic AI and Turning Insight Into Action

Qlik Connect: Mike Capone On Agentic AI and Turning Insight Into Action

What does it actually take to move AI from experimentation into something a business can depend on every single day? Recording live from the show floor at Qlik Connect in Florida, I sat down with Qlik...

14 Apr 18min

Twilio: Demystifying Model Context Protocol (MCP) And Real-World AI Deployment

Twilio: Demystifying Model Context Protocol (MCP) And Real-World AI Deployment

How are brands supposed to deliver AI-powered customer experiences when their data is scattered across systems that were never designed to work together? In this episode, I sit down with Peter Bell, V...

14 Apr 34min

Invisible Technologies CEO On Building AI Around Real Workflows, Not Hype

Invisible Technologies CEO On Building AI Around Real Workflows, Not Hype

What does it actually take to make AI work inside a real business, where messy data, human judgment, and operational risk all collide? In this episode, I sit down with Matt Fitzpatrick, CEO of Invisib...

13 Apr 29min

Willow On How AI Is Changing The Way Buildings Operate

Willow On How AI Is Changing The Way Buildings Operate

In this episode, I speak with Bert Van Hoof, CEO of Willow, about how AI is starting to reshape the built world in ways that go far beyond smart dashboards and efficiency reports. Bert brings decades ...

12 Apr 48min

Blumberg Capital On What Investors Really Want From AI Founders Now

Blumberg Capital On What Investors Really Want From AI Founders Now

What does it really take to build the next generation of AI companies when the hype around scale begins to fade and real-world impact takes center stage? In this episode, I sit down with David Blumber...

11 Apr 47min

AI Psychosis Explained With Dr. Ragy Girgis From Columbia University

AI Psychosis Explained With Dr. Ragy Girgis From Columbia University

How do we talk about artificial intelligence without ignoring the very human consequences it can have on our mental health? In this episode, I sit down with Dr. Ragy Girgis, Professor of Clinical Psyc...

10 Apr 24min

Populärt inom Politik & nyheter

svenska-fall
rss-krimstad
aftonbladet-krim
p3-krim
flashback-forever
blenda-2
rss-sanning-konsekvens
politiken
aftonbladet-daily
rss-krimreportrarna
motiv
rss-vad-fan-hande
spar
grans
rss-frandfors-horna
rss-flodet
svd-ledarredaktionen
dagens-eko
olyckan-inifran
spotlight